139 related articles for article (PubMed ID: 8915585)
61. Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells.
Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Tetich M; Kubera M; Leśkiewicz M; Lasoń W
Eur J Pharmacol; 2004 Jul; 495(2-3):103-10. PubMed ID: 15249158
[TBL] [Abstract][Full Text] [Related]
62. The mitochondrion as a primary site of action of glucocorticoids: mitochondrial nucleotide sequences, showing similarity to hormone response elements, confer dexamethasone inducibility to chimaeric genes transfected in LATK- cells.
Tsiriyotis C; Spandidos DA; Sekeris CE
Biochem Biophys Res Commun; 1997 Jun; 235(2):349-54. PubMed ID: 9199195
[TBL] [Abstract][Full Text] [Related]
63. Regulation of vasopressin messenger RNA levels in the small cell lung carcinoma cell line GLC-8: interactions between glucocorticoids and second messengers.
Verbeeck MA; Sutanto W; Burbach JP
Mol Endocrinol; 1991 Jun; 5(6):795-801. PubMed ID: 1717834
[TBL] [Abstract][Full Text] [Related]
64. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3',5'-monophosphate, and phorbol esters, and inhibition by insulin.
Suh DS; Ooi GT; Rechler MM
Mol Endocrinol; 1994 Jun; 8(6):794-805. PubMed ID: 7523864
[TBL] [Abstract][Full Text] [Related]
65. Molecular analysis of estrogen induction of preproenkephalin gene expression and its modulation by thyroid hormones.
Zhu YS; Cai LQ; You X; Duan Y; Imperato-McGinley J; Chin WW; Pfaff DW
Brain Res Mol Brain Res; 2001 Jul; 91(1-2):23-33. PubMed ID: 11457489
[TBL] [Abstract][Full Text] [Related]
66. Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A.
Nordeen SK; Bona BJ; Moyer ML
Mol Endocrinol; 1993 Jun; 7(6):731-42. PubMed ID: 8395651
[TBL] [Abstract][Full Text] [Related]
67. Enhancement of glucocorticoid receptor-mediated gene expression by cellular stress: evidence for the involvement of a heat shock-initiated factor or process during recovery from stress.
Hu JL; Guan XJ; Sánchez ER
Cell Stress Chaperones; 1996 Sep; 1(3):197-205. PubMed ID: 9222605
[TBL] [Abstract][Full Text] [Related]
68. Relative glucocorticoid potency revisited.
Tanaka H; Hirano F; Nomura Y; Miura T; Makino Y; Fukawa E; Makino I
Rheumatol Int; 1994; 14(1):9-12. PubMed ID: 7939139
[TBL] [Abstract][Full Text] [Related]
69. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene.
Malkoski SP; Handanos CM; Dorin RI
Mol Cell Endocrinol; 1997 Mar; 127(2):189-99. PubMed ID: 9099914
[TBL] [Abstract][Full Text] [Related]
70. Analysis of the mechanism of glucocorticoid-mediated down regulation of the mouse alpha-fetoprotein gene.
Rabek JP; Zhang DE; Torres-Ramos CA; Papaconstantinou J
Biochim Biophys Acta; 1994 Jun; 1218(2):136-44. PubMed ID: 7517187
[TBL] [Abstract][Full Text] [Related]
71. Expression of the enkephalin precursor gene in C6 rat glioma cells: regulation by beta-adrenergic agonists and glucocorticoids.
Yoshikawa K; Sabol SL
Brain Res; 1986 Jul; 387(1):75-83. PubMed ID: 2874871
[TBL] [Abstract][Full Text] [Related]
72. Glucocorticoids and cyclic AMP synergistically regulate the abundance of preproenkephalin messenger RNA in neuroblastoma-glioma hybrid cells.
Yoshikawa K; Sabol SL
Biochem Biophys Res Commun; 1986 Aug; 139(1):1-10. PubMed ID: 3021119
[TBL] [Abstract][Full Text] [Related]
73. Positive and negative regulation of the rat vasopressin gene promoter.
Iwasaki Y; Oiso Y; Saito H; Majzoub JA
Endocrinology; 1997 Dec; 138(12):5266-74. PubMed ID: 9389510
[TBL] [Abstract][Full Text] [Related]
74. Vitamin B6 modulates glucocorticoid-dependent gene transcription in a promoter- and cell type-specific manner.
Bamberger CM; Else T; Ellebrecht I; Milde-Langosch K; Pankoke D; Beil FU; Bamberger AM
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):595-600. PubMed ID: 15578335
[TBL] [Abstract][Full Text] [Related]
75. Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation.
Ikonen T; Palvimo JJ; Kallio PJ; Reinikainen P; Jänne OA
Endocrinology; 1994 Oct; 135(4):1359-66. PubMed ID: 7925097
[TBL] [Abstract][Full Text] [Related]
76. Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone.
Lim JA; Kim SH
BMB Rep; 2009 Jul; 42(7):421-6. PubMed ID: 19643039
[TBL] [Abstract][Full Text] [Related]
77. A cyclic AMP- and phorbol ester-inducible DNA element.
Comb M; Birnberg NC; Seasholtz A; Herbert E; Goodman HM
Nature; 1986 Sep 25-Oct 1; 323(6086):353-6. PubMed ID: 3020428
[TBL] [Abstract][Full Text] [Related]
78. Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells.
Pepperl DJ; Regan JW
Mol Pharmacol; 1993 Oct; 44(4):802-9. PubMed ID: 8232231
[TBL] [Abstract][Full Text] [Related]
79. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?
Ray A; LaForge KS; Sehgal PB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7086-90. PubMed ID: 1871124
[TBL] [Abstract][Full Text] [Related]
80. Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone.
Balbín M; López-Otín C
J Biol Chem; 1996 Jun; 271(25):15175-81. PubMed ID: 8663058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]